Accueil > Publications > Simeprevir versus telaprevir with peginterferon and ribavirin in previous null or partial responders with chronic hepatitis C virus genotype 1 infection (ATTAIN): a randomised, double-blind, non-inferiority phase 3 trial
Simeprevir versus telaprevir with peginterferon and ribavirin in previous null or partial responders...